Cargando…

The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is one of the most commonly performed bariatric procedures and has proven effective in providing weight loss. However, considerable variance has been noted in the degree of weight loss. Physician prescription practices may be negatively affecting wei...

Descripción completa

Detalles Bibliográficos
Autores principales: Leggett, Cecilia B., Desalermos, Athanasios, Brown, Steven D., Lee, Euyhyun, Proudfoot, James A., Horgan, Santiago, Gupta, Samir, Grunvald, Eduardo, Ho, Samuel B., Zarrinpar, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428627/
https://www.ncbi.nlm.nih.gov/pubmed/30242239
http://dx.doi.org/10.1038/s41366-018-0207-x
_version_ 1783405422586101760
author Leggett, Cecilia B.
Desalermos, Athanasios
Brown, Steven D.
Lee, Euyhyun
Proudfoot, James A.
Horgan, Santiago
Gupta, Samir
Grunvald, Eduardo
Ho, Samuel B.
Zarrinpar, Amir
author_facet Leggett, Cecilia B.
Desalermos, Athanasios
Brown, Steven D.
Lee, Euyhyun
Proudfoot, James A.
Horgan, Santiago
Gupta, Samir
Grunvald, Eduardo
Ho, Samuel B.
Zarrinpar, Amir
author_sort Leggett, Cecilia B.
collection PubMed
description BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is one of the most commonly performed bariatric procedures and has proven effective in providing weight loss. However, considerable variance has been noted in the degree of weight loss. Physician prescription practices may be negatively affecting weight loss post-LSG and, thus, contributing to the broad range of weight loss outcomes. The aim of our study was to determine whether commonly prescribed obesogenic medications negatively affect weight loss outcomes post-LSG. SUBJECTS/METHODS: This single center retrospective cohort study performed at a University hospital included 323 patients (≥18 years) within University California, San Diego Healthcare System who underwent LSG between 2007 and 2016. We identified a list of 32 commonly prescribed medications that have weight gain as a side effect. We compared the percent excess weight loss (%EWL) of patients divided into two groups based on post-LSG exposure to obesogenic medications. A linear regression model was used to analyze %EWL at 12 months post-LSG while controlling for age, initial body mass index (BMI), and use of leptogenic medications. RESULTS: 150 patients (Meds group) were prescribed obesogenic medications within the one-year post-LSG follow up period, whereas 173 patients (Control group) were not prescribed obesogenic medications. The Meds group lost significantly less weight compared to the Control group (%EWL ± SEM at 12 months 53.8 ± 2.4 n=78, 65.0 ± 2.6, n=84 respectively, P = 0.002). This difference could not be attributed to differences in age, gender, initial BMI, co-morbidities, or prescription of leptogenic medications between the two groups. CONCLUSIONS: The use of provider-prescribed obesogenic medications was associated with worse weight loss outcomes post-LSG. Closer scrutiny of patient medications may be necessary to help improve outcomes of weight loss treatments.
format Online
Article
Text
id pubmed-6428627
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-64286272019-03-21 The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study Leggett, Cecilia B. Desalermos, Athanasios Brown, Steven D. Lee, Euyhyun Proudfoot, James A. Horgan, Santiago Gupta, Samir Grunvald, Eduardo Ho, Samuel B. Zarrinpar, Amir Int J Obes (Lond) Article BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) is one of the most commonly performed bariatric procedures and has proven effective in providing weight loss. However, considerable variance has been noted in the degree of weight loss. Physician prescription practices may be negatively affecting weight loss post-LSG and, thus, contributing to the broad range of weight loss outcomes. The aim of our study was to determine whether commonly prescribed obesogenic medications negatively affect weight loss outcomes post-LSG. SUBJECTS/METHODS: This single center retrospective cohort study performed at a University hospital included 323 patients (≥18 years) within University California, San Diego Healthcare System who underwent LSG between 2007 and 2016. We identified a list of 32 commonly prescribed medications that have weight gain as a side effect. We compared the percent excess weight loss (%EWL) of patients divided into two groups based on post-LSG exposure to obesogenic medications. A linear regression model was used to analyze %EWL at 12 months post-LSG while controlling for age, initial body mass index (BMI), and use of leptogenic medications. RESULTS: 150 patients (Meds group) were prescribed obesogenic medications within the one-year post-LSG follow up period, whereas 173 patients (Control group) were not prescribed obesogenic medications. The Meds group lost significantly less weight compared to the Control group (%EWL ± SEM at 12 months 53.8 ± 2.4 n=78, 65.0 ± 2.6, n=84 respectively, P = 0.002). This difference could not be attributed to differences in age, gender, initial BMI, co-morbidities, or prescription of leptogenic medications between the two groups. CONCLUSIONS: The use of provider-prescribed obesogenic medications was associated with worse weight loss outcomes post-LSG. Closer scrutiny of patient medications may be necessary to help improve outcomes of weight loss treatments. 2018-09-21 2019-06 /pmc/articles/PMC6428627/ /pubmed/30242239 http://dx.doi.org/10.1038/s41366-018-0207-x Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Leggett, Cecilia B.
Desalermos, Athanasios
Brown, Steven D.
Lee, Euyhyun
Proudfoot, James A.
Horgan, Santiago
Gupta, Samir
Grunvald, Eduardo
Ho, Samuel B.
Zarrinpar, Amir
The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title_full The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title_fullStr The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title_full_unstemmed The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title_short The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
title_sort effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: a retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6428627/
https://www.ncbi.nlm.nih.gov/pubmed/30242239
http://dx.doi.org/10.1038/s41366-018-0207-x
work_keys_str_mv AT leggettceciliab theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT desalermosathanasios theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT brownstevend theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT leeeuyhyun theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT proudfootjamesa theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT horgansantiago theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT guptasamir theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT grunvaldeduardo theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT hosamuelb theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT zarrinparamir theeffectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT leggettceciliab effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT desalermosathanasios effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT brownstevend effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT leeeuyhyun effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT proudfootjamesa effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT horgansantiago effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT guptasamir effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT grunvaldeduardo effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT hosamuelb effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy
AT zarrinparamir effectsofproviderprescribedobesogenicdrugsonpostlaparoscopicsleevegastrectomyoutcomesaretrospectivecohortstudy